Vogt-koyanagi-harada Disease
📧 Sign up to get email alerts when something new happens for Vogt-koyanagi-harada Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH
A clinical trial comparing oral prednisolone to posterior sub-Tenon triamcinolone for acute Vogt-Koyanagi-Harada disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I [NA]
Completed results from a multimodal analysis and electroretinography study in Vogt-Koyanagi-Harada disease (uveomeningoencephalitic syndrome…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
A clinical trial evaluating adalimumab for acute Vogt-Koyanagi-Harada disease is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Intravitreal Bevacizumab for Inflammatory Neovascular Membranes [Phase 3]
Phase 3 trial of intravitreal bevacizumab for inflammatory neovascular membranes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment [Phase 2, Phase 3]
Phase 2/3 trial update evaluating suprachoroidal triamcinolone acetonide for Vogt-Koyanagi-Harada disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.